RAS/MAPK activation Is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors.
- Publication date
- 15 March 2016
- Publisher
- MaineHealth Knowledge Connection